Complications associated with chemotherapy in XXXX management.

@entity1 @entity251 @entity250 @entity5 @entity73 @entity900 @entity344 @entity158 @entity209 @entity65 @entity2530
@entity5 is the most common solid @entity5 among @entity1 aged 15-35 years. The introduction of @entity900 -based chemotherapy has resulted in a cure rate of over 95% for @entity1 with @entity5 , which has put increased emphasis on understanding the morbidity associated with chemotherapy. Hematological, @entity344 are the most common acute adverse effects. Although most @entity1 recover, some of these effects can persist after the chemotherapy regimen has been completed and can become chronic problems. The late complications associated with @entity900 -based chemotherapy include secondary @entity5 , @entity65 , @entity2530 , and @entity73 . Late complications can have considerable effects on survival and quality of life, so close monitoring of @entity1 is critical for the early diagnosis of late adverse effects and to limit associated damage. All @entity1 should adopt a healthy lifestyle and follow age-appropriate @entity5 screening programs. Hormonal supplementation should be considered for those with a low @entity251 level, in order to reduce the risk of @entity250 and @entity209 . Prompt diagnosis of @entity2530 is essential, and it should be considered in the differential diagnosis for any long-term @entity5 survivor complaining of @entity158 . Finally, sperm cryopreservation should be discussed with all @entity1 before chemotherapy is initiated.
